Cell Culture Media Market Research Report—Global Forecast till 2027

Cell Culture Media Market: Information by Product Type (Classical Media, Stem Cell Media, Serum-free Media), by Application (Drug Discovery and Drug Development, Toxicity Testing, Cancer Research, Genetic Engineering, Tissue Engineering & Biochemistry), by End User (Biotechnology & Pharmaceutical Companies, Research Laboratories, Academic Institutes, Pathology Lab), and by Region (Americas, Europe, Asia-Pacific, and Middle East & Africa)—Forecast till 2027

ID: MRFR/HC/3049-CR | August 2021 | Region: Global | 159 pages

Impact of COVID-19 on the Cell Culture Media Market


Cell culture media finds its usage in various applications such as research and therapeutics. It is an important role in research as it can be used to study functions, metabolic regulations, and cell physiology of various organisms. In addition, they are also used for purposes such as vaccine production, genetic engineering drug screening as well as toxicity testing, and prenatal diagnosis among others.


Countries and various industries are trying to deal with the challenges thrown up by the novel coronavirus (COVID-19), and one such industry of concern has been the uncertainty surrounding the impact of the COVID-19 pandemic on the global cell culture media market. Considering that the global spread of COVID-19 has dramatically increased the number of suspected cases and the geographic area where laboratory testing needed to be implemented, intensified. COVID-19 situation has led to shortages of cell culture media and reagents globally. Beyond supply issues, there are significant limitations of absorption capacity in many regions, especially in low- and middle-income countries.


Testing remains a crucial step to control the rapid spread of the virus. And these testing involves the usage of cell culture media and assays that help to understand the presence of the virus in one’s body.  With an increasing number of cases, governments across the world are exploring the opportunities of allowing private laboratories to ramp up testing. The wide availability of diagnostics will be required for the immediate detection of COVID-19 cases. World Health Organization (WHO) developed testing strategy recommendations, as part of the Strategic Preparedness and Response Plan. The foundation of this strategy includes:



  • Testing in areas with community transmission and in settings where testing capacity cannot meet needs must be prioritized. It should focus on the early detection and protection of vulnerable patients and health care workers.



  • Focused testing in health care facilities ensures that infection prevention and control measures can be correctly implemented such that vulnerable patients who do not have COVID are protected from nosocomial COVID-19 infection.

  • Testing among vulnerable populations and risk groups will be important for early treatment to minimize progression to severe disease.


Total Covid-19 Diagnostic Tests Performed by Country as of March 20, 2020
Total Covid-19 Diagnostic Tests Performed


Source-World Data and MRFR Analysis


Initiatives and Support by Government:



  • Australia issued an exemption for devices involved in the diagnosis, confirmatory testing, prevention, monitoring, treatment, or alleviation of COVID-19.



  • On 4th Feb 2020, the Food and Drug Administration (US FDA) issued a new policy to accelerate the availability of diagnostics. A public health emergency was determined, justifying the authorization of emergency use of in-vitro diagnostics (IVDs) for the diagnosis of COVID-19.



  • The U.S. Food and Drug Administration (FDA) has approved 20 manufacturers and kits for diagnostic testing for COVID-19. For instance, on Mar. 12, 2020, Roche Diagnostics received the EUA (Emergency Use Authorization) for its novel coronavirus diagnostic test, Cobas SARS-CoV-2 Test from the US FDA, which will be soon made available in India.



  • In India, The Indian Council of Medical Research (ICMR) has approved 176 labs, including 47 private labs, to conduct the tests.


These new policies by various governments in improving the diagnostic and testing process will eventually lead to growth in the cell culture media market as they are important components in the testing of viruses.


Assays, and reagents are an important aspect of diagnostics tests for COVID-19.  Hence, the cell culture media industry needs to keep up with demand, despite suppliers’ factories shutting down production, reduced factory working hours, limited workforce, and often, the shutdown of research and development. It is certainly a challenge to bring innovative new products to the market during these times. However, a quality diagnosis which provides faster and accurate test results is the need of the hour.



TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYNOPSIS
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 LIST OF ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 WIDE RANGE OF APPLICATIONS OF CELL CULTURE
4.2.2 RISING RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL INDUSTRY
4.2.3 GROWING PREVALENCE OF CHRONIC DISEASES
4.2.4 INCREASING EXPANSION & PRODUCT LAUNCH BY MAJOR PLAYERS
4.2.5 DRIVERS IMPACT ANALYSIS
4.3 RESTRAINTS
4.3.1 HIGH COST AND RISK OF CONTAMINATION OF MEDIA
4.3.2 RESTRAINTS IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 INCREASING USE OF REGENERATIVE MEDICINE
5 MARKET FACTOR ANALYSIS
5.1 SUPPLY CHAIN ANALYSIS
5.1.1 RAW MATERIAL
5.1.2 SUPPLIERS
5.1.3 MANUFACTURERS
5.1.4 DISTRIBUTORS
5.1.5 CUSTOMER-RETAILERS
5.1.6 CONSUMERS
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CELL CULTURE MEDIA MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON CLINICAL TRIALS
5.3.3 IMPACT OF LABORATORY DEVELOPED TESTS (LDT) TO DIAGNOSE COVID-19
5.3.4 IMPACT ON TEST VOLUME, REVENUE, AND STAFFING
5.4 PROCEDURE AND CONSUMPTION ANALYSIS
5.4.1 PROCEDURE ANALYSIS
5.4.2 CONSUMPTION ANALYSIS
6 GLOBAL CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 CLASSICAL MEDIA
6.3 STEM CELL MEDIA
6.4 SERUM-FREE MEDIA
7 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 DRUG DISCOVERY AND DRUG DEVELOPMENT
7.3 TOXICITY TESTING
7.4 CANCER RESEARCH
7.5 GENETIC ENGINEERING
7.6 TISSUE ENGINEERING & BIOCHEMISTRY
8 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER
8.1 OVERVIEW
8.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
8.3 RESEARCH LABORATORIES
8.4 ACADEMIC INSTITUTES
8.5 PATHOLOGY LABS
9 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION
9.1 OVERVIEW
9.2 AMERICAS
9.2.1 NORTH AMERICA
9.2.1.1 US
9.2.1.2 CANADA
9.2.2 LATIN AMERICA
9.3 EUROPE
9.3.1 WESTERN EUROPE
9.3.1.1 GERMANY
9.3.1.2 FRANCE
9.3.1.3 UK
9.3.1.4 ITALY
9.3.1.5 SPAIN
9.3.1.6 REST OF WESTERN EUROPE
9.3.2 EASTERN EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 AUSTRALIA
9.4.5 SOUTH KOREA
9.4.6 REST OF ASIA-PACIFIC
9.5 MIDDLE EAST & AFRICA
9.5.1 MIDDLE EAST
9.5.2 AFRICA
10 COMPETITIVE LANDSCAPE: GLOBAL CELL CULTURE MEDIA MARKET
10.1 OVERVIEW
10.2 COMPETITIVE ANALYSIS
10.3 COMPETITIVE BENCHMARKING
10.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS
10.5 MAJOR GROWTH STRATEGY IN THE GLOBAL CELL CULTURE MEDIA MARKET
10.5.1 ACQUISITION & PARTNERSHIP
10.5.2 EXPANSION
10.5.3 PRODUCT LAUNCH
10.5.4 COLLABORATION
11 COMPANY PROFILES
11.1 THERMO FISHER SCIENTIFIC INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 MERCK KGAA
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 BECTON, DICKINSON AND COMPANY
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 GE HEALTHCARE
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 BIO-RAD LABORATORIES, INC.
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 DANAHER CORPORATION
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 BIOMÉRIEUX SA
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 LONZA
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS/SERVICES OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 SWOT ANALYSIS
11.8.6 KEY STRATEGIES
11.9 AGILENT TECHNOLOGIES, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 HIMEDIA LABORATORIES
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 SWOT ANALYSIS
11.10.6 KEY STRATEGIES
11.11 CORNING INCORPORATED
11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL OVERVIEW
11.11.3 PRODUCTS/SERVICES OFFERED
11.11.4 KEY DEVELOPMENTS
11.11.5 SWOT ANALYSIS
11.11.6 KEY STRATEGIES
11.12 PROMOCELL
11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL OVERVIEW
11.12.3 PRODUCTS/SERVICES OFFERED
11.12.4 KEY DEVELOPMENTS
11.12.5 SWOT ANALYSIS
11.12.6 KEY STRATEGIES
11.13 THE SARTORIUS GROUP
11.13.1 COMPANY OVERVIEW
11.13.2 FINANCIAL OVERVIEW
11.13.3 PRODUCTS/SERVICES OFFERED
11.13.4 KEY DEVELOPMENTS
11.13.5 SWOT ANALYSIS
11.13.6 KEY STRATEGIES
11.14 FUJIFILM HOLDINGS CORPORATION
11.14.1 COMPANY OVERVIEW
11.14.2 FINANCIAL OVERVIEW
11.14.3 PRODUCTS/SERVICES OFFERED
11.14.4 KEY DEVELOPMENTS
11.14.5 SWOT ANALYSIS
11.14.6 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS

LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, 2017-2020 (NUMBER OF LABS PERFORMING CELL CULTURE)
TABLE 3 US CELL CULTURE MEDIA MARKET, BY END USER, 2017-2020 (NUMBER OF LABS PERFORMING CELL CULTURE)
TABLE 4 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, 2017-2020 (VOLUME BY LITRE)
TABLE 5 US CELL CULTURE MEDIA MARKET, BY END USER, 2017-2020 (VOLUME BY LITRE)
TABLE 6 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, 2017-2020 (NUMBER OF PROCEDURES)
TABLE 7 US CELL CULTURE MEDIA MARKET, BY END USER, 2017-2020 (NUMBER OF PROCEDURES )
TABLE 8 GLOBAL CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 9 GLOBAL CELL CULTURE MEDIA MARKET, FOR CLASSICAL MEDIA, BY REGION, 2017-2027 (USD MILLION)
TABLE 10 GLOBAL CELL CULTURE MEDIA MARKET, FOR STEM CELL MEDIA, BY REGION, 2017-2027 (USD MILLION)
TABLE 11 GLOBAL CELL CULTURE MEDIA MARKET, FOR STEM CELL MEDIA, BY TYPE, 2017-2027 (USD MILLION)
TABLE 12 GLOBAL CELL CULTURE MEDIA MARKET, FOR SERUM-FREE MEDIA, BY REGION, 2017-2027 (USD MILLION)
TABLE 13 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 14 GLOBAL CELL CULTURE MEDIA MARKET, FOR DRUG DISCOVERY AND DRUG DEVELOPMENT, BY REGION, 2017-2027 (USD MILLION)
TABLE 15 GLOBAL CELL CULTURE MEDIA MARKET, FOR TOXICITY TESTING, BY REGION, 2017-2027 (USD MILLION)
TABLE 16 GLOBAL CELL CULTURE MEDIA MARKET, FOR CANCER RESEARCH, BY REGION, 2017-2027 (USD MILLION)
TABLE 17 GLOBAL CELL CULTURE MEDIA MARKET, FOR GENETIC ENGINEERING, BY REGION, 2017-2027 (USD MILLION)
TABLE 18 GLOBAL CELL CULTURE MEDIA MARKET, FOR TISSUE ENGINEERING & BIOCHEMISTRY, BY REGION, 2017-2027 (USD MILLION)
TABLE 19 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 20 GLOBAL CELL CULTURE MEDIA MARKET, FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2017-2027 (USD MILLION)
TABLE 21 GLOBAL CELL CULTURE MEDIA MARKET, FOR RESEARCH LABORATORIES, BY REGION, 2017-2027 (USD MILLION)
TABLE 22 GLOBAL CELL CULTURE MEDIA MARKET, FOR ACADEMIC INSTITUTES, BY REGION, 2017-2027 (USD MILLION)
TABLE 23 GLOBAL CELL CULTURE MEDIA MARKET, FOR PATHOLOGY LABS, BY REGION, 2017-2027 (USD MILLION)
TABLE 24 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 25 AMERICAS: CELL CULTURE MEDIA MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 26 AMERICAS: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 27 AMERICAS: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 28 AMERICAS: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 29 AMERICAS: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 30 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 31 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 32 NORTH AMERICA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 33 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 34 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 35 US: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 36 US: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 37 US: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 38 US: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 39 CANADA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 40 CANADA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 41 CANADA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 42 CANADA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 43 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 44 LATIN AMERICA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 45 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 46 LATIN AMERICA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 47 EUROPE: CELL CULTURE MEDIA MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 48 EUROPE: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 49 EUROPE: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 50 EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 51 EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 52 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 53 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 54 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 55 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 56 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 57 GERMANY: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 58 GERMANY: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 59 GERMANY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 60 GERMANY: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 61 FRANCE: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 62 FRANCE: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 63 FRANCE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 64 FRANCE: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 65 UK: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 66 UK: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 67 UK: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 68 UK: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 69 ITALY: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 70 ITALY: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 71 ITALY: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 72 ITALY: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 73 SPAIN: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 74 SPAIN: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 75 SPAIN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 76 SPAIN: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 77 REST OF WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 78 REST OF WESTERN EUROPE: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 79 REST OF WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 80 REST OF WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 81 EASTERN EUROPE: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 82 EASTERN EUROPE: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 83 EASTERN EUROPE: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 84 EASTERN EUROPE: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 85 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2017-2027 (USD MILLION)
TABLE 86 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 87 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 88 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 89 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 90 CHINA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 91 CHINA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 92 CHINA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 93 CHINA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 94 JAPAN: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 95 JAPAN: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 96 JAPAN: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 97 JAPAN: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 98 INDIA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 99 INDIA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 100 INDIA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 101 INDIA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 102 AUSTRALIA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 103 AUSTRALIA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 104 AUSTRALIA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 105 AUSTRALIA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 106 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 107 SOUTH KOREA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 108 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 109 SOUTH KOREA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 110 REST OF ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 111 REST OF ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 114 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY REGION, 2017-2027 (USD MILLION)
TABLE 115 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 119 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 120 MIDDLE EAST: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 121 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 122 MIDDLE EAST: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 123 AFRICA: CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2017-2027 (USD MILLION)
TABLE 124 AFRICA: CELL CULTURE MEDIA MARKET, FOR STEM CELL CULTURE, BY TYPE, 2017-2027 (USD MILLION)
TABLE 125 AFRICA: CELL CULTURE MEDIA MARKET, BY APPLICATION, 2017-2027 (USD MILLION)
TABLE 126 AFRICA: CELL CULTURE MEDIA MARKET, BY END USER, 2017-2027 (USD MILLION)
TABLE 127 GLOBAL CELL CULTURE MEDIA MARKET, COMPANY RANKING ANALYSIS, 2019
TABLE 128 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE CELL CULTURE MEDIA MARKET
TABLE 129 ACQUISITION & PARTNERSHIP
TABLE 130 EXPANSION
TABLE 131 PRODUCT LAUNCH
TABLE 132 COLLABORATION
TABLE 133 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
TABLE 134 THERMO FISHER SCIENTIFIC INC.: KEY DEVELOPMENTS
TABLE 135 MERCK KGAA: PRODUCTS/SERVICES OFFERED
TABLE 136 MERCK KGAA: KEY DEVELOPMENTS
TABLE 137 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED
TABLE 138 GE HEALTHCARE: PRODUCTS/SERVICES OFFERED
TABLE 139 GE HEALTHCARE: KEY DEVELOPMENTS
TABLE 140 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 141 GE HEALTHCARE: KEY DEVELOPMENTS
TABLE 142 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 143 DANAHER CORPORATION: KEY DEVELOPMENTS
TABLE 144 BIOMÉRIEUX SA: PRODUCTS/SERVICES OFFERED
TABLE 145 BIOMÉRIEUX SA: KEY DEVELOPMENTS
TABLE 146 LONZA: PRODUCTS/SERVICES OFFERED
TABLE 147 LONZA: KEY DEVELOPMENTS
TABLE 148 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 149 AGILENT TECHNOLOGIES, INC.: KEY DEVELOPMENTS
TABLE 150 HIMEDIA LABORATORIES: PRODUCTS/SERVICES OFFERED
TABLE 151 CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED
TABLE 152 PROMOCELL: PRODUCTS/SERVICES OFFERED
TABLE 153 THE SARTORIUS GROUP: PRODUCTS/SERVICES OFFERED
TABLE 154 FUJIFILM HOLDINGS CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 155 FUJIFILM HOLDINGS CORPORATION: KEY DEVELOPMENTS


LIST OF FIGURES
FIGURE 1 GLOBAL CELL CULTURE MEDIA MARKET STRUCTURE
FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CELL CULTURE MEDIA MARKET
FIGURE 4 SUPPLY CHAIN ANALYSIS: GLOBAL CELL CULTURE MEDIA MARKET
FIGURE 5 PORTER’S FIVE FORCES MODEL
FIGURE 6 GLOBAL CELL CULTURE MEDIA MARKET, BY PRODUCT TYPE, 2019 & 2027 (USD MILLION)
FIGURE 7 GLOBAL CELL CULTURE MEDIA MARKET, BY APPLICATION, 2019 & 2027 (USD MILLION)
FIGURE 8 GLOBAL CELL CULTURE MEDIA MARKET, BY END USER, 2019 & 2027 (USD MILLION)
FIGURE 9 GLOBAL CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 10 AMERICAS: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 11 NORTH AMERICA: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)
FIGURE 12 EUROPE: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 13 WESTERN EUROPE: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)
FIGURE 14 ASIA-PACIFIC: CELL CULTURE MEDIA MARKET, BY COUNTRY, 2019 & 2027 (USD MILLION)
FIGURE 15 MIDDLE EAST & AFRICA: CELL CULTURE MEDIA MARKET, BY REGION, 2019 & 2027 (USD MILLION)
FIGURE 16 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 17 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CELL CULTURE MEDIA MARKET
FIGURE 18 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 20 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 MERCK KGAA: SWOT ANALYSIS
FIGURE 22 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
FIGURE 24 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 GE HEALTHCARE: SWOT ANALYSIS
FIGURE 26 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 28 DANAHER CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 DANAHER CORPORATION: SWOT ANALYSIS
FIGURE 30 BIOMÉRIEUX SA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 BIOMÉRIEUX SA: SWOT ANALYSIS
FIGURE 32 LONZA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 LONZA: SWOT ANALYSIS
FIGURE 34 AGILENT TECHNOLOGIES, INC.: FINANCIAL OVERVIEW
FIGURE 35 AGILENT TECHNOLOGIES, INC.: SWOT ANALYSIS
FIGURE 36 HIMEDIA LABORATORIES: SWOT ANALYSIS
FIGURE 37 CORNING INCORPORATED: FINANCIAL OVERVIEW
FIGURE 38 ORNING INCORPORATED: SWOT ANALYSIS
FIGURE 39 PROMOCELL: SWOT ANALYSIS
FIGURE 40 THE SARTORIUS GROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 41 THE SARTORIUS GROUP: SWOT ANALYSIS
FIGURE 42 FUJIFILM HOLDINGS CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 FUJIFILM HOLDINGS CORPORATION: SWOT ANALYSIS



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.